BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32773788)

  • 1. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
    Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
    Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma.
    Bílek R; Vlček P; Šafařík L; Michalský D; Novák K; Dušková J; Václavíková E; Widimský J; Zelinka T
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31027285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
    Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases.
    Kawashima A; Sone M; Inagaki N; Okamoto K; Tsuiki M; Izawa S; Otsuki M; Okamura S; Ichijo T; Katabami T; Takeda Y; Yoshimoto T; Naruse M; Tanabe A
    Endocrine; 2021 Oct; 74(1):155-162. PubMed ID: 34272648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.
    Eisenhofer G; Peitzsch M; Bechmann N; Huebner A
    Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma.
    Raber W; Kotal H; Marculescu R; Scheuba C; Niederle MB; Kautzky-Willer A; Krebs M
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32993074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection.
    Weingarten TN; Welch TL; Moore TL; Walters GF; Whipple JL; Cavalcante A; Bancos I; Young WF; Gruber LM; Shah MZ; McKenzie TJ; Schroeder DR; Sprung J
    Urology; 2017 Feb; 100():131-138. PubMed ID: 27769919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
    Goupil R; Fountoulakis S; Gordon RD; Stowasser M
    J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metanephrine and normetanephrine associated with subclinical myocardial injuries in pheochromocytoma and paraganglioma.
    Yu Y; Chen C; Han W; Zhang Y; Zhang Z; Yang Y
    Front Oncol; 2022; 12():1024342. PubMed ID: 36237312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
    Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.